EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Bioinformatics-driven discovery of shared biomarkers linking depression and cognitive impairment

Weizhi Chen, Bin Li

Advances in Clinical and Experimental Medicine · 2026

DOI: 10.17219/acem/209879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2026. Verfasst von Weizhi Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington Scientific Institute, Fairfax, USA. Hauptthemen laut MEDLINE: Computational Biology, Cognitive Dysfunction, Major Depressive Disorder. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Major depressive disorder (MDD) is frequently comorbid with mild cognitive impairment (MCI), yet its molecular basis remains unclear. OBJECTIVES: This study aimed to identify shared differentially expressed genes (DEGs) and biological pathways that may underlie the comorbidity between MDD and MCI. Using integrative bioinformatics approaches applied to transcriptomic datasets, we sought to uncover molecular biomarkers that could inform early diagnosis and provide novel targets for mechanism-based therapeutic strategies. MATERIAL AND METHODS: Transcriptomic datasets from MDD (GSE58430) and MCI (GSE140831) patients were analyzed to identify DEGs. Functional enrichment analyses were performed using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Protein-protein interaction (PPI) networks were constructed to identify core genes. RESULTS: A total of 301 DEGs were shared between MDD and MCI. Gene Ontology and KEGG enrichment analyses revealed key biological processes involved in neuroinflammation, oxidative stress, synaptic dysfunction, and apoptotic signaling. The PPI network analysis identified nine hub genes with high connectivity: HSP90AB1, CDC42, NFKB1, CD8A, CALM3, PARP1, CD44, H2BC21, and MYH9. CONCLUSIONS: These findings reveal shared molecular biomarkers and pathways linking MDD and MCI, providing insights into their comorbidity. The identified core genes, particularly PARP1 and CDC42, may serve as novel targets for early diagnosis and mechanism-based therapeutic strategies in psychiatry and neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Computational BiologyCognitive DysfunctionMajor Depressive DisorderHumansBiomarkersProtein Interaction MapsGene Expression ProfilingDatabases, GeneticTranscriptomeGene Regulatory Networks

Stichwörter der Autor:innen

bioinformaticsbiomarkersgene expressionmajor depressive disordermild cognitive impairment

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Washington Scientific Institute, Fairfax, USA.

Zitieren

APA

Chen, W., & Li, B. (2026). Bioinformatics-driven discovery of shared biomarkers linking depression and cognitive impairment. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/209879

Vancouver

Chen W, Li B. Bioinformatics-driven discovery of shared biomarkers linking depression and cognitive impairment. Advances in Clinical and Experimental Medicine. 2026. doi:10.17219/acem/209879

BibTeX
@article{Chen2026,
  author = {Chen, Weizhi and Li, Bin},
  title = {Bioinformatics-driven discovery of shared biomarkers linking depression and cognitive impairment},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2026},
  doi = {10.17219/acem/209879}
}
Kostenlos starten →